All News #Library
Others
Kiadis abandons lead PhIII program, shifts focus to natural killer cells
12 Nov 2019 //
ENDPTS
Kiadis Pharma completes acquisition of CytoSen Therapeutics, Inc.
05 Jun 2019 //
BIOSPACE
Stem cell transplant firms Kiadis and CytoSen join forces
18 Apr 2019 //
ENDPTS
Kiadis to buy CytoSen, adding June to advisory board
17 Apr 2019 //
FIERCE BIOTECH

Market Place
Sourcing Support